Weight Loss Clinical Trials in Chicago, IL

17 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	2 mi
A Novel Intervention for Weight Loss in Young Adults	N/A	University of Chicago	2 mi
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss	N/A	Northwestern University	2 mi
Randomized Control Trial of Sleeve Gastrectomy with Tirzepatide in Maximizing Weight Loss	Early 1	Nicholas Skertich	2 mi
SMARTer Weight Loss Management	N/A	Northwestern University	2 mi
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer	N/A	University of Illinois at Chicago	2 mi
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers	N/A	University of Illinois at Chicago	2 mi
DNA Methylation and Vascular Function	N/A	University of Illinois at Chicago	2 mi
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation	Phase 2/3	AgelessRx	2 mi
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass	N/A	Boston Scientific Corporation	2 mi
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation	Phase 3	University of Chicago	2 mi
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues	Early 1	University of Chicago	2 mi
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists	—	Northwestern University	2 mi
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	8 mi
Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss	—	Boston Scientific Corporation	12 mi
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue	Phase 2/3	Pfizer	17 mi
A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance	Phase 4	AbbVie	26 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.